Abstract:figure legend Loss of plakophilin2 (PKP2) in the mouse atrium leads to impaired cell–cell contact and extensive fibrotic remodelling (middle). PKP2‐deficient atrial cardiomyocytes exhibit enhanced sarcomere shortening and impaired relaxation, potentially related to reduced abundance of myosin binding protein C (left). In addition, PKP2‐deficient atrial cardiomyocytes present increased spontaneous sarcoplasmic reticulum (SR) calcium (Ca2+) release events, further enhanced by isoproterenol exposure and reversible by a ryanodine receptor (RyR) blocker (dantrolene). SR Ca2+ leak is probably caused by elevated levels of oxidative stress (ROS) in the mitochondria (right). Atrial arrhythmias occur in 20–40% of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) and are associated with an increased risk of sustained ventricular arrhythmias and inappropriate implantable cardioverter‐defibrillator shocks. The pathophysiology of atrial arrhythmias in ARVC remains unclear. Most cases of gene‐positive ARVC are linked to pathogenic variants in the desmosomal gene plakophilin‐2 (PKP2). Here, we test the hypothesis that loss of PKP2 expression leads to pro‐arrhythmic changes in atrial cardiomyocytes. Atrial cells/tissue were obtained from a cardiac‐specific, tamoxifen‐activated model of PKP2 deficiency (PKP2cKO). By contrast to PKP2cKO ventricular myocytes, PKP2cKO atrial cardiomyocytes presented no significant differences in intracellular calcium (Ca2+i) transient dynamics, sarcoplasmic reticulum load or action potential morphology. PKP2cKO atrial cardiomyocytes showed elevated reactive oxygen species levels, increased frequency and amplitude of Ca2+ sparks, and increased diastolic [Ca2+]i compared to control; the latter two parameters were further increased by isoproterenol exposure and reversed by exposure to ryanodine receptor blocker dantrolene. We speculate that these isoproterenol‐dependent effects may impact on the exercise‐related atrial arrhythmia risk in ARVC patients. Despite absence of changes in Ca2+i transient dynamics, PKP2cKO atrial cardiomyocytes showed enhanced sarcomere shortening and impaired sarcomere relaxation. Orthogonal transcriptomic analysis of human(GTEx) and PKP2cKO atrial tissue led to identification of 41 transcripts depending on PKP2 expression. Biochemical follow‐up confirmed reduced abundance of sarcomeric protein myosin binding protein C, potentially playing a role in cellular shortening and relaxation changes observed. Our findings provide novel insights into the role of PKP2 in atrial myocardium with potential implications to therapeutic management of atrial fibrillation in patients with PKP2‐related ARVC. Key points Atrial arrhythmias occur in a large group of patients with arrhythmogenic right ventricular cardiomyopathy (ARVC), a cardiac disease mostly caused by pathogenic variants in the desmosomal gene plakophilin‐2 (PKP2). Exercise is considered to be an independent risk factor for arrhythmias consequent to PKP2 deficiency. We show that loss of PKP2 expression affects cellular calcium handling and electrophysiology differently in left atrial vs. ventricular myocardium and causes extensive atrial fibrosis. PKP2‐deficient atrial cardiomyocytes present increased spontaneous sarcoplasmic reticulum calcium release events, further enhanced by isoproterenol exposure and reversible by a ryanodine receptor blocker (dantrolene). In addition, PKP2‐deficient atrial myocytes exhibit impaired relaxation and enhanced sarcomere shortening, most probably related to reduced abundance of myosin binding protein C. We speculate that cellular effects reported upon isoproterenol impact on the exercise‐related atrial arrhythmia risk in ARVC patients. We further propose that therapeutic approaches aimed at mitigating ventricular damage may be effective to treat the atrial disease in ARVC.

Polycystin-1 loss of function increases susceptibility to atrial fibrillation through impaired DNA damage response

Decreased polycystin 2 expression alters calcium-contraction coupling and changes β-adrenergic signaling pathways

Protein Phosphatase 1α Interacts with a Novel Ciliary Targeting Sequence of Polycystin‐1 and Regulates Polycystin‐1 Trafficking

Cardiac Localized Polycystin-2 plays a Functional Role in Natriuretic Peptide Production and its Absence Contributes to Hypertension

Cardiac Deficiency of P21-activated Kinase 1 Promotes Atrial Arrhythmogenesis in Mice Following Adrenergic Challenge.

Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys.

Programmed Cell Death-1 Deficiency Results In Atrial Remodeling In C57bl/6 Mice

Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease

Myocardin-related transcription factor drives epithelial fibrogenesis in polycystic kidney disease

Polycystin-1 Downregulation Induced Vascular Smooth Muscle Cells Phenotypic Alteration and Extracellular Matrix Remodeling in Thoracic Aortic Dissection

PPP1R12C Promotes Atrial Hypocontractility in Atrial Fibrillation

Sperm morphological abnormalities in autosomal dominant polycystic kidney disease are associated with the Hippo signaling pathway via PC1

Atrial cardiomyopathy resulting from loss of plakophilin‐2 expression: Response to adrenergic stimulation and implications for the exercise response

Computational Modeling of Effects of PKP2 Gene Therapy on Ventricular Conduction Properties in Arrhythmogenic Cardiomyopathy

Aortic Dissection is Associated with Reduced Polycystin-1 Expression, an Abnormality That Leads to Increased ERK Phosphorylation in Vascular Smooth Muscle Cells.

Inhibiting Focal Adhesion Kinase Ameliorates Cyst Development in Polycystin-1-Deficient Polycystic Kidney Disease in Animal Model

ADPKD-Causing Missense Variants in Polycystin-1 Disrupt Cell Surface Localization or Polycystin Channel Function

Myocardin-Related Transcription Factor Mediates Epithelial Fibrogenesis in Polycystic Kidney Disease

Loss of protein phosphatase 2A regulatory subunit PPP2R5A is associated with increased incidence of stress-induced proarrhythmia

Reduced decay-accelerating factor expression promotes complement-mediated cystogenesis in murine ADPKD

Leaky RyR2 channels as pro-arrhythmic trigger in the PKP2-deficient atrial myocardium